MIM
BVS icon

Meros Investment Management’s Bioventus BVS Stock Holding History

Meros Investment Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-207,720
Closed -$1.9M – 52
2026
Q1 		$1.9M Sell
207,720
-107,440
-34% -$901K 0.82% 35
2025
Q4 		$2.34M Buy
+315,160
New +$2.27M 0.93% 33
2022
Q1 		– Sell
-114,100
Closed -$1.65M – 36
2021
Q4 		$1.65M Buy
+114,100
New +$1.62M 1.21% 31

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Meros Investment Management's BVS Position: Q2 2026 in Review

Meros Investment Management sold out of Bioventus (BVS) in Q2 2026, closing a stake of 207,720 shares — an estimated $1.9M sold.

Meros Investment Management first reported a position in BVS in Q4 2021 and held it in 3 quarters. The position peaked at $2.34M in Q4 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Meros Investment Management reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
  • Meros Investment Management sold 207,720 Bioventus shares in Q2 2026, an estimated $1.9M.
  • Meros Investment Management first reported a position in Bioventus in Q4 2021 and held it in 3 quarters.
  • Meros Investment Management's Bioventus position peaked at $2.34M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Meros Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.